Added on May 2, 2024
KV Network
Covaxin developed with single-minded focus on safety first: Bharat Biotech
NEW DELHI, May 2 (PTI): Bharat Biotech on Thursday asserted that its Covid-19 vaccine Covaxin is safe and devoid of any side-effects amid AstraZeneca’s admission that Covishield could cause complications in rare cases.
In a statement, the company stated that Covaxin was developed with a single-minded focus on safety first, followed by efficacy.
The vaccine was evaluated in more than 27,000 subjects as part of its licensure process, Bharat Biotech stated.